Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic
  • Search Hotels in Santa Clara

  • ROOMS:

Gilead Sciences Presents at ECCMID 2022 - Continues Mission to Advance Access to Effective Therapies

By: 3BL Media

SOURCE: Gilead Sciences


The data we presented at ECCMID 2022 is part of Gilead’s mission to advance access to effective therapies. We've helped transform the treatment and prevention of HIV and delivered HCV cures as a result of our deep scientific understanding of viruses and expertise in antiviral drug development.

View original content here.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Gilead Website

Tweet me: The data @GileadSciences presented at #ECCMID2022 is part of their mission to advance access to effective therapies.

KEYWORDS: NYSE:GILD, Gilead Sciences, ECCMID 2022

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2010-2020 & California Media Partners, LLC. All rights reserved.